Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
CRISPR/Cas-Based Molecular Diagnostics for Intestinal Parasites: From Proof-of-Concept to Point-of-Care Testing
- 1Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, , Jeddah 21589, Saudi Arabia;
Related
- Prevalence of intestinal parasites and associated factors among HIV patients receiving antiretroviral therapy at public hospitals in North Shoa Zone, Oromia, Ethiopia: Cross-sectional study
- Editorial: Molecular and phylogenetic insights for diagnostics and vaccine development
- Comprehensive Molecular Profiling for Precision Diagnostics: Integrating Genomic, Proteomic, and Epigenetic Landscapes in Human Pathology
- Early Use of Molecular Diagnostics in the Emergency Department Reduces All-Cause Mortality in Patients with Pneumonia at Risk of Multidrug-Resistant Pathogens
- Genome Profiling of Actionable Cancer Targets (NYU LG-PACT) for Clinical Patient Molecular Diagnostics and Treatment
BibTeX
@article{alsaady2026crisprcasbased,
title = {{CRISPR/Cas-Based Molecular Diagnostics for Intestinal Parasites: From Proof-of-Concept to Point-of-Care Testing}},
author = {Isra M. Alsaady},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702924},
note = {CC BY},
}
RIS
TY - JOUR
TI - CRISPR/Cas-Based Molecular Diagnostics for Intestinal Parasites: From Proof-of-Concept to Point-of-Care Testing
AU - Isra M. Alsaady
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13702924
SN - 2075-4418
ER -